Remove Advocacy Remove DEA Remove Sleep Remove Treatment
article thumbnail

DEA Approves Cocaine Derivative for Parkinson’s Research. Why Not Cannabis?

Veriheal

But recent news of the DEA’s approval of a cocaine derivative for Parkinson’s disease research has left us scratching our heads. After receiving a petition three years prior, the DEA finally answered with action, making plans to deschedule [18F]FP-CIT , a controlled substance derived from cocaine.

DEA 98
article thumbnail

AAFP ( American Academy of Family Physicians) Releases Marijuana, Cannabinoids Position Paper

Cannabis Law Report

The AAFP urges its members to be involved in the diagnosis, treatment, and prevention of substance use, as well as secondary diseases impacted or caused by use. The AAFP recognizes the benefits of intervention and treatment for the recreational use of marijuana, in lieu of incarceration, for all individuals, including youth.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Lighting Up Florida’s Medical Marijuana People: The Medics Series, Part 6

Cannabis Law Report

Cannabis is not a “gateway” drug, according to the ASA and the DEA’s own statements cited in the August 2016 U.S. Usage of over-the-counter pain relievers and sleep aids, as well as prescription pain relievers and anti-anxiety medications dropped” . Federal Register. . – Citations from U.S.

article thumbnail

Minorities in cannabis, with Steven Philpott Jr.

The Cannigma

We always have a nice little tidbit when we’re all about advocacy and access to cannabis for all. Is this as needed for sleep? They’re college athletes, or they’re not sleeping, their bodies aren’t recovering. And proficiency testing right now, because of the DEA is very limited in what can get sent out.